RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
New Borderline Personality Disorder Medication; worldwide patent for well-known molecule in major psychiatric indication
Buprenorphine for Borderline Personality Disorder: A new psychiatric patented medication More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Pine Rest Christian Mental Health Services - Strategic SWOT Analysis Review
May 2011 - 15 pages - $125
National Institute of Mental Health (NIMH) – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Other Psychiatric Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 76 pages - $1,000
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Centre for Addiction and Mental Health – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 25 pages - $500
Schizophrenia Global Clinical Trials Review, Q1, 2011
Jan 2011 - 94 pages - $1,000
Beersheva Mental Health Center – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 28 pages - $500
Psychiatric Solutions, Inc. - SWOT Analysis
Apr 2010 - 20 pages - $125
CNS Market Access in China - Investment in mental health services offers growth opportunities for psychiatry players
Jul 2011 - 98 pages - $5,700
CNS Market Access in India: Government investment into CNS services set to stimulate market growth
Jun 2011 - 99 pages - $5,700
More Related Market Research Reports >>>

Your selection

Therapeutic target
Central Nervous System del
Psychiatric del
Mental health (other) del
Development phase
Preclinical del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us